14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:DRNA
Delisted

Dicerna Pharmaceuticals Stock Price (Quote)

$38.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.22 $38.22 Friday, 27th May 2022 DRNA stock ended at $38.22. During the day the stock fluctuated 0% from a day low at $38.22 to a day high of $38.22.
90 days $38.22 $38.22
52 weeks $19.06 $40.14

Historical Dicerna Pharmaceuticals prices

Date Open High Low Close Volume
Feb 20, 2019 $10.74 $10.76 $10.30 $10.43 419 298
Feb 19, 2019 $11.44 $11.69 $10.70 $10.75 427 888
Feb 15, 2019 $10.79 $11.48 $10.68 $11.44 416 940
Feb 14, 2019 $10.86 $11.01 $10.50 $10.71 313 540
Feb 13, 2019 $10.85 $11.15 $10.56 $10.89 381 926
Feb 12, 2019 $10.33 $10.83 $10.29 $10.83 338 108
Feb 11, 2019 $10.01 $10.34 $9.83 $10.32 160 573
Feb 08, 2019 $9.94 $10.03 $9.75 $9.95 308 617
Feb 07, 2019 $10.10 $10.24 $9.78 $9.96 286 289
Feb 06, 2019 $10.38 $10.43 $10.11 $10.16 258 610
Feb 05, 2019 $10.86 $11.20 $10.35 $10.37 250 774
Feb 04, 2019 $10.55 $11.12 $10.53 $10.81 300 369
Feb 01, 2019 $10.32 $10.54 $10.10 $10.54 254 192
Jan 31, 2019 $10.02 $10.69 $9.99 $10.31 368 478
Jan 30, 2019 $9.86 $10.25 $9.69 $10.05 550 959
Jan 29, 2019 $9.80 $9.99 $9.39 $9.87 393 855
Jan 28, 2019 $9.86 $10.07 $9.56 $9.74 791 325
Jan 25, 2019 $10.31 $10.41 $9.82 $10.15 437 939
Jan 24, 2019 $10.28 $10.51 $9.91 $10.26 362 951
Jan 23, 2019 $10.98 $11.17 $10.15 $10.31 330 585
Jan 22, 2019 $11.63 $12.08 $10.82 $10.94 508 916
Jan 18, 2019 $11.18 $11.32 $10.70 $10.77 411 447
Jan 17, 2019 $10.64 $11.18 $10.63 $11.16 271 786
Jan 16, 2019 $10.89 $11.48 $10.64 $10.67 192 154
Jan 15, 2019 $10.41 $10.96 $10.32 $10.87 365 726
Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... DRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT